Literature DB >> 24648562

Multilocus sequence typing of serially collected isolates of Cryptococcus from HIV-infected patients in South Africa.

Marelize Van Wyk1, Nelesh P Govender2, Thomas G Mitchell3, Anastasia P Litvintseva4.   

Abstract

Patients with cryptococcal meningitis in sub-Saharan Africa frequently relapse following treatment. The natural history and etiology of these recurrent episodes warrant investigation. Here, we used multilocus sequence typing (MLST) to compare the molecular genotypes of strains of Cryptococcus neoformans and Cryptococcus gattii isolated from serial episodes of cryptococcal meningitis that were separated by at least 110 days. The most common MLST genotypes among the isolates were the dominant global clinical genotypes (M5 and M4) of molecular type VNI, as well as the VNI genotypes apparently restricted to southern Africa. In addition, there was considerable genetic diversity among these South African isolates, as 15% of the patients had unique genotypes. Eleven percent of the patients were reinfected with a genetically different strain following their initial diagnosis and treatment. However, the majority of serial episodes (89%) were caused by strains with the same genotype as the original strain. These results indicate that serial episodes of cryptococcosis in South Africa are frequently associated with persistence or relapse of the original infection. Using a reference broth microdilution method, we found that the serial isolates of 11% of the patients infected with strains of C. neoformans var. grubii with identical genotypes exhibited ≥4-fold increases in the MICs to fluconazole. Therefore, these recurrent episodes may have been precipitated by inadequate induction or consolidation of antifungal treatment and occasionally may have been due to increased resistance to fluconazole, which may have developed during the chronic infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24648562      PMCID: PMC4042789          DOI: 10.1128/JCM.03177-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.

Authors:  B J Park; S Shetty; A Ahlquist; A Greenbaum; J L Miller; A Motsi; K McCarthy; N Govender
Journal:  Int J STD AIDS       Date:  2011-04       Impact factor: 1.359

2.  Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment.

Authors:  Edward Sionov; Yun C Chang; Kyung J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

3.  Poor long-term outcomes for cryptococcal meningitis in rural South Africa.

Authors:  Richard J Lessells; Portia C Mutevedzi; Tom Heller; Marie-Louise Newell
Journal:  S Afr Med J       Date:  2011-04

4.  Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.

Authors:  J Xu; C Onyewu; H J Yoell; R Y Ali; R J Vilgalys; T G Mitchell
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

5.  Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea.

Authors:  Young Hwa Choi; Popchai Ngamskulrungroj; Ashok Varma; Edward Sionov; Soo Myung Hwang; Fabian Carriconde; Wieland Meyer; Anastasia P Litvintseva; Wee Gyo Lee; Jong Hee Shin; Eui-Chong Kim; Kyung Won Lee; Tae Yeal Choi; Yeong Seon Lee; Kyung J Kwon-Chung
Journal:  FEMS Yeast Res       Date:  2010-05-19       Impact factor: 2.796

6.  Comparative analysis of environmental and clinical populations of Cryptococcus neoformans.

Authors:  Anastasia P Litvintseva; Lori Kestenbaum; Rytas Vilgalys; Thomas G Mitchell
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

7.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

8.  Evidence that the human pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa.

Authors:  Anastasia P Litvintseva; Ignazio Carbone; Jenny Rossouw; Rameshwari Thakur; Nelesh P Govender; Thomas G Mitchell
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

9.  Population genetic analyses reveal the African origin and strain variation of Cryptococcus neoformans var. grubii.

Authors:  Anastasia P Litvintseva; Thomas G Mitchell
Journal:  PLoS Pathog       Date:  2012-02-23       Impact factor: 6.823

10.  Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China.

Authors:  Jianghan Chen; Ashok Varma; Mara R Diaz; Anastasia P Litvintseva; Kurt K Wollenberg; Kyung J Kwon-Chung
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more
  22 in total

Review 1.  Cryptococcosis diagnosis and treatment: What do we know now.

Authors:  John R Perfect; Tihana Bicanic
Journal:  Fungal Genet Biol       Date:  2014-10-13       Impact factor: 3.495

2.  Rising to the challenge of multiple Cryptococcus species and the diseases they cause.

Authors:  Alexander Idnurm; Xiaorong Lin
Journal:  Fungal Genet Biol       Date:  2015-05-14       Impact factor: 3.495

3.  Molecular type distribution and fluconazole susceptibility of clinical Cryptococcus gattii isolates from South African laboratory-based surveillance, 2005-2013.

Authors:  Serisha D Naicker; Carolina Firacative; Erika van Schalkwyk; Tsidiso G Maphanga; Juan Monroy-Nieto; Jolene R Bowers; David M Engelthaler; Wieland Meyer; Nelesh P Govender
Journal:  PLoS Negl Trop Dis       Date:  2022-06-29

4.  Plasma But Not Cerebrospinal Fluid Interleukin 7 and Interleukin 5 Levels Pre-Antiretroviral Therapy Commencement Predict Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.

Authors:  Ngomu Akeem Akilimali; Christina C Chang; Daniel M Muema; Tarylee Reddy; Mahomed-Yunus S Moosa; Sharon R Lewin; Martyn A French; Thumbi Ndung'u
Journal:  Clin Infect Dis       Date:  2017-10-16       Impact factor: 9.079

5.  Genotype, Antifungal Susceptibility, and Virulence of Clinical South African Cryptococcus neoformans Strains from National Surveillance, 2005-2009.

Authors:  Serisha D Naicker; Rindidzani E Magobo; Tsidiso G Maphanga; Carolina Firacative; Erika van Schalkwyk; Juan Monroy-Nieto; Jolene Bowers; David M Engelthaler; Liliwe Shuping; Wieland Meyer; Nelesh P Govender
Journal:  J Fungi (Basel)       Date:  2021-04-27

6.  Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa.

Authors:  Mathew A Beale; Wilber Sabiiti; Emma J Robertson; Karen M Fuentes-Cabrejo; Simon J O'Hanlon; Joseph N Jarvis; Angela Loyse; Graeme Meintjes; Thomas S Harrison; Robin C May; Matthew C Fisher; Tihana Bicanic
Journal:  PLoS Negl Trop Dis       Date:  2015-06-25

7.  Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis.

Authors:  Joshua Rhein; Nathan C Bahr; Bozena M Morawski; Charlotte Schutz; Yonglong Zhang; Malcolm Finkelman; David B Meya; Graeme Meintjes; David R Boulware
Journal:  Open Forum Infect Dis       Date:  2014-11-26       Impact factor: 3.835

8.  Comparative analyses of clinical and environmental populations of Cryptococcus neoformans in Botswana.

Authors:  Yuan Chen; Anastasia P Litvintseva; Aubrey E Frazzitta; Miriam R Haverkamp; Liuyang Wang; Charles Fang; Charles Muthoga; Thomas G Mitchell; John R Perfect
Journal:  Mol Ecol       Date:  2015-07-07       Impact factor: 6.185

Review 9.  Ecoepidemiology of Cryptococcus gattii in Developing Countries.

Authors:  Patricia F Herkert; Ferry Hagen; Rosangela L Pinheiro; Marisol D Muro; Jacques F Meis; Flávio Queiroz-Telles
Journal:  J Fungi (Basel)       Date:  2017-11-03

10.  Glucosamine stimulates pheromone-independent dimorphic transition in Cryptococcus neoformans by promoting Crz1 nuclear translocation.

Authors:  Xinping Xu; Jianfeng Lin; Youbao Zhao; Elyssa Kirkman; Yee-Seul So; Yong-Sun Bahn; Xiaorong Lin
Journal:  PLoS Genet       Date:  2017-09-12       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.